FluTrackers

Tracking Infectious Diseases since 2006

PayPal Verified medpedia.com

FluTrackers.com Inc. is a 501(c)(3) charity

Nederlandse taal Foro de Español de FluTrackers Francophones des FluTrackers Forum Italiano FluTrackers Latest Posts

www www.flutrackers.com



Go Back   FluTrackers > South America > Seasonal Flu 2009 - 2013 1/2 including H1N1 pandemic 2009 > Argentina

Reply
 
Thread Tools Search this Thread Display Modes
  #1  
Old May 10th, 2010, 09:47 AM
Tonka's Avatar
Tonka Tonka is offline
Editor, Senior Moderator
 
Join Date: May 2009
Posts: 10,409
Default Sublingual immuno recommended to improve the prevention of influenza A H1N1.

http://www.noticiasmedicas.es/medici...N1-/Page1.html

Sublingual immuno recommended to improve the prevention of influenza A H1N1.

Specialists advised how to prepare for this winter.


- Use associated with the flu vaccine boosted by 60% the protective effect of the vaccine and 50% reduced recurrent infections

- Argentina was one of the countries most affected by the pandemic. In 2009 there were more than 1.4 million cases of influenza, both A and seasonal.


Buenos Aires, May 2010 .- The H1N1 influenza pandemic that swept the world during 2009 was particularly severe in Argentina, with a high number of cases and a higher mortality than in other countries. That is why this year are taking extreme measures to prevent: in addition to specific influenza vaccine, some experts recommend a sublingual immunostimulant that enhances the immune response to the aggression of the virus.

This compound, widely used in Europe, was shown to improve influenza vaccine efficacy, and prevent respiratory infections significantly more common. Dr. Jorge San Juan, head of the Department of Intensive Care Patient Critical Infectious Infectious Diseases Hospital "Francisco J. Muñiz ", said:" Clinical research has shown that the use of immune-associated sublingual flu vaccine boosted by 60% the protective effect of the vaccine reduced by 50% of recurrences compared to isolated use of the vaccine and decreased 60% the need for antibiotics. "

The immunostimulating sublingual stimulates a better immune response through two distinct mechanisms: first, it reinforces the production of NK cells, natural killer, fighting a virus-infected cells, on the other, produces antibodies against bacteria producing 8 78 % of respiratory infections. It can be administered to adults and children two years of age belonging to risk groups and to anyone who wants to prevent respiratory diseases, with an outline of three months of treatment, the rate of one tablet daily for ten days, rest 20 days and restarted the scheme. It has a good safety profile, and there are no reported undesirable side effects associated with their use.

Belonging to risk groups of children 6-23 months, pregnant women, those over 64 years, health professionals, people with heart or lung disease, chronic renal failure, diabetes or asthma and immunosuppressed (cancer, HIV and others), that make in total just over 12 million people in Argentina.

Dr. Carlos Luna, Chief of Pulmonary Critical Pulmonary Division of the Hospital de Clinicas "José de San Martín", noted that "among the main measures of prevention, we must have the vaccination schedule to date, maintain hygienic living habits healthy, and consult with your doctor about the convenience of oral immunostimulants.

Finally, Dr. Ana Balanzat, chief of pediatric pulmonology at the Hospital de Clinicas "José de San Martín", advised hygiene measures that tend to avoid infection: wash your hands (with water and soap or alcohol gel) avoid meetings with sick people or where people conglomerate, no smoking or remain in environments contaminated by smoke snuff, retreat at the first signs of a cold, cough and sneeze into the inside of the elbow, among others. "

Fewer infections

One trial in patients older than 18 years showed a decrease of 83% of respiratory infections in the respiratory tract (both viral and bacterial) compared to the placebo group, showing that among those who received the immunostimulant, 79% did not suffer any respiratory infectious episode , versus 4% free of infection in the control group.

Respiratory Diseases in Argentina


Disease No. of cases 2009 *

Influenza (flu) 1.4 million

220 000 Pneumonia

Bronchiolitis 230 000

* Ministry of Health of The Nation. Year 2009


Another study, conducted in children with recurrent respiratory infections showed a significant reduction of respiratory infections (viral and bacterial): 68% of those receiving medication remained free of infection, versus 37% in children to who were given other immunostimulant. The duration of the episodes and antibiotic use was reduced by half in the group treated with sublingual immunostimulant.

Respiratory Infections

Dr. Eduardo Lopez, head of the Department of Medicine, Hospital de Niños "Ricardo Gutiérrez", explained that in 2009 "there were 1.4 million cases of avian influenza or states, 220 000 230 000 pneumonia and bronchiolitis, which gives a true parameter of the high incidence of these diseases, which can become very aggressive when they affect the most vulnerable people, making up the so called "risk groups". " It is estimated that every year in the country 50 000 people for respiratory diseases.

Fragments that immunize

The immunostimulating sublingual (Ismigen ®, Merck Serono), contains a lysate (pieces) of 48 billion bacteria belonging to the species most often attack the airways, causing 78% of respiratory infections. These are: Staphylococcus aureus, Streptococcus pyogenes, Streptococcus viridans, Klebsiella pneumoniae, Klebsiella ozaenae, Haemophilus influenzae type B, Neisseria catarrhalis and Diplococcus pneumoniae. The lysate stimulates the immune system in general, increasing its capacity to respond to the attacks of bacteria, viruses and other microorganisms.

About Merck Serono

Merck Serono is the division for prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. With headquarters in Darmstadt, Germany, Merck Serono discovers, develops and produces and commercializes innovative molecules and biopharmaceuticals to meet the clinical needs of patients waiting for solutions. Its North American business unit operates in the United States and Canada under the name EMD Serono.

Merck Serono has leading biotechnology therapeutic branches that help cancer patients with multiple sclerosis, infertility, endocrine and cardiometabolic disorders.

With an annual investment in R & D of approximately 1,000 million euros, Merck Serono is committed to increasing its business in areas specific therapeutic including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas that emerge from research and development in autoimmune and inflammatory diseases.

About Merck

Merck is a global pharmaceutical and chemical company with a history that began in 1668 and whose future is up to 32 458 employees in 59 countries. The company's success is characterized by innovations from initiatives of its employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds approximately 70% of the shares and the remaining 30% is held by independent shareholders. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has since became an independent company.
Reply With Quote
Reply


Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools Search this Thread
Search this Thread:

Advanced Search
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On


Disclaimers:

The reader is responsible for discerning the validity, factuality or implications of information posted here, be it fictional or based on real events. Moderators on this forum make every effort to review the material posted on this site however, it is not realistically possible for our staff to manually review each post.

The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original authors or posters and are not endorsed by, or representative of the opinions of, the owners or administration of this website. The posts on this website are the opinion of the specific author or poster and should not be construed as statements of advice or factual information.

Not all posts on this website are intended as truthful or factual assertion by their authors. NO posts on this website should be considered factual information on face value alone. Users are encouraged to USE DISCERNMENT and do their own follow up research while reading and posting on this website. FluTrackers.com Inc. reserves the right to make changes to, corrections and/or remove entirely at any time posts made on this website without notice. In addition, FluTrackers.com Inc. disclaims any and all liability for damages incurred directly or indirectly as a result of a post on this website.

This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall FluTrackers.com Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site.

Finally, FluTrackers.com Inc. reserves the right to delete, correct, or make changes to any post on this website without notice at any time for any reason.

Fair Use Notice:
This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to public health, civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes.

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 1 paragraph, and in no case more than 50% of the source material provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember you are responsible for what you post on the internet and you could be sued by the original copyright holder if you do not honor these rules.

If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright

we may be contacted concerning copyright matters at:

FluTrackers.com Inc.
c/o Sharon Sanders
1676 Hibiscus Avenue
Winter Park, Florida 32789
Phone: 407-745-1513
E-Mail: flutrackers@earthlink.net

In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein.

If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question.

All 3rd party material posted on this website is the copyright of the respective owners / authors. FluTrackers.com Inc. makes no claim of copyright on such material.

For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Please be aware any communications sent complaining about a post on this website may be posted publicly at the discretion of the administration.

FluTrackers Does Not Provide Any Medical Advice:

FluTrackers, Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.

The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.

By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.

By using and/or accessing this site, either passively or actively, you are agreeing to all of the above conditions. Also, by using and/or accessing this site, either passively or actively, you agree to conduct all business and legal affairs related to this website in the jurisdiction of Flutrackers.com Inc. which is registered in Central Florida, USA.

These Disclaimers are subject to change at anytime.

Email the Webmaster with questions or comments about this site at flutrackers@earthlink.net


All times are GMT -4. The time now is 08:36 AM.


H1N1 Influenza Swine Flu Avian Flu Infectious Diseases. Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
Template-Modifications by TMS